Fundraising Fox
Prana Therapies
Encinitas, US · Founded 2024 · Delaware corporation
Find your way into Prana Therapies
Sign up to see every warm intro you have to Prana Therapies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Prana Therapies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MS
Miguel SanjuanFounder and Strategic Scientific AdvisorMiguel Sanjuan is executive officer and director at Prana Therapies, which develops regeneration therapies for diabetes treatment.
SG
Sheila GujrathiFounder and CEOSheila Gujrathi is an MD with over 25 years in biotech and pharmaceuticals, having previously served as CMO at Receptos (acquired by Celgene), co-founder and CEO of Gossamer Bio, and held leadership roles in immunology at Bristol-Myers Squibb and Genentech; she earned her BS in biomedical engineering and MD from Northwestern University and completed clinical training in internal medicine and allergy/immunology at Brigham and Women's Hospital, Harvard Medical School, UCSF, and Stanford University.
BA
Ben AuspitzNamed on SEC filing
AB
Alexis BorisyNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$45.2M disclosed across 2 rounds · 2024–2025
▶$40.2MraisedAug 2026 · 9 investors · BiotechnologyRule 506(b)
▶$40.2MraisedAug 2026 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ben AuspitzDirector
- Alexis BorisyDirector
- Sheila Gujrathi, M.D.Executive Officer, Director
- Hector OrtegaExecutive Officer
- Ryan SullivanExecutive Officer
- Offering amount
- $40.2M
- Amount sold
- $40.2M
- First sale
- Nov 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$5MraisedJul 2024 · 2 investors · BiotechnologyRule 506(b)
▶$5MraisedJul 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Miguel SanjuanExecutive Officer, Director
- Sheila GujrathiExecutive Officer, Director
- Offering amount
- $9M
- Amount sold
- $5M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2024
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Prana Therapies went on to found or lead other companies.
Frequently asked questions
- How much funding has Prana Therapies raised?
- Prana Therapies has disclosed $45.2M raised across 2 rounds.
- Where is Prana Therapies headquartered?
- Prana Therapies is headquartered in Encinitas, US.